Effects of Coenzyme Q10 on Early Parkinson Disease

Effects of Coenzyme Q10 on Early Parkinson Disease (QE3) - The purpose of this study is to evaluate the safety and effectiveness of high dosages of Coenzyme Q10 in slowing clinical decline in people who have early Parkinson Disease.

 

If you have:

1) been diagnosed with PD within the last 5 years

2) are not currently on medication for PD

 

you may qualify for this study.

 

It will include 7 scheduled visits and may last up to 17 months or sooner if it is determined that the patient requires treatment with PD medications.